Emre Yekedüz (@yekeduz_emre) 's Twitter Profile
Emre Yekedüz

@yekeduz_emre

MD, Genitourinary Medical Oncologist | Faculty @AnkaraUni | Researcher @DanaFarber_GU @Harvard | Translational Oncol | Editorial Board @BMC_series @OncJournal

ID: 2735430730

linkhttps://coi.asco.org/share/6UB-THQV/Emre%20Yekeduz calendar_today06-08-2014 19:37:17

6,6K Tweet

2,2K Followers

973 Following

Emre Yekedüz (@yekeduz_emre) 's Twitter Profile Photo
Emre Yekedüz
@yekeduz_emre

2 months ago

Avelumab 1L maintenance vs best supportive care after platinum based chemo in advanced urothelial cancer; ⭐️Non-visceral mets: OS➡️31.4 vs 17.1 months (HR:0.6) and LN-only disease: OS➡️31.9 vs 22.7 months (HR:0.8) ⭐️Durable outcomes + manageable safety ➡️➡️still promising

Avelumab 1L maintenance vs best supportive care after platinum based chemo in advanced urothelial cancer; ⭐️Non-visceral mets: OS➡️31.4 vs 17.1 months (HR:0.6) and LN-only disease: OS➡️31.9 vs 22.7 months (HR:0.8) ⭐️Durable outcomes + manageable safety ➡️➡️still promising